ACTU Actuate Therapeutics, Inc. - Common stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026
$0.82
· of 52w range
· above low
· to high
$0.6052w low
$8.4952w high
Market Cap (MRQ)
$20M
P/E
-0.8
EPS
$-1.06
your badges
52W Range
$1–$8
Analyst Rating
BUY
Price Target
$12
P/E
-0.8
ROE
-843.5%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ACTU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.82
Market Cap (MRQ)
$20M
P/E
-0.8
EPS
$-1.06
ROE
-843.5%
52W Range
$1–$8
ACTU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-1.062023-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ACTU | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.8 | · | · | · | |
| P/B (MRQ) | 19.9 | · | 1.5 | Overvalued | |
| Price / Cash Flow | -1.0 | · | · | · | |
| Price / Tangible Book | 2.4 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ACTU | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -190.3% | · | -70.7% | Weak | |
| ROE | -843.5% | · | -79.1% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ACTU | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.2 | · | 1.8 | Below avg | |
| Quick Ratio | 2.3 | · | 1.6 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
2.1%
Next Report
Nov 13, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 14, 2026 | $-0.20 | $-0.19 | -5.0% |
| March 31, 2026 | May 14, 2026 | $-0.24 | $-0.22 | -8.6% |
| Dec. 31, 2025 | $-0.18 | $-0.25 | 28.0% | |
| Sept. 30, 2025 | $-0.25 | $-0.28 | 11.7% | |
| June 30, 2025 | $-0.31 | $-0.32 | 3.5% | |
| March 31, 2025 | $-0.32 | $-0.31 | -3.4% | |
| Dec. 31, 2024 | $-0.33 | $-0.30 | -11.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $10M | $19M | $22M | |
| SG&A Expense | $12M | $6M | $3M | |
| Operating Expenses | $22M | $25M | $25M | |
| Operating Income | $-22M | $-25M | $-25M | |
| Interest Income | $287.7K | $222.3K | $352.7K | |
| Other Non-op | $267.5K | $-2M | $229.2K | |
| Income Tax | $800 | $800 | $0 | |
| Net Income | $-22M | $-27M | $-25M | |
| EPS (Basic) | $-1.06 | $-3.26 | $-17.24 | |
| EPS (Diluted) | $-1.06 | $-3.26 | $-17.24 | |
| Shares (Basic) | 21,021,817 | 8,372,741 | 1,434,964 | |
| Shares (Diluted) | 21,021,817 | 8,372,741 | 1,434,964 | |
| EBITDA | $-22M | $-25M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $13M | $9M | · | |
| Prepaid Expense | $484.0K | $566.3K | $36.9K | |
| Current Assets | $14M | $9M | $3M | |
| Other Non-current Assets | $392.5K | $110.5K | $0 | |
| Total Assets | $14M | $9M | $3M | |
| Accounts Payable | $2M | $2M | $3M | |
| Current Liabilities | $6M | $9M | $7M | |
| Total Liabilities | $6M | $9M | $8M | |
| Common Stock | $23 | $20 | $2 | |
| Paid-in Capital | $163M | $132M | $5M | |
| Retained Earnings | $-155M | $-132M | $-105M | |
| Stockholders' Equity | $8M | $104.2K | $-100M | |
| Liabilities + Equity | $14M | $9M | $3M | |
| Shares Outstanding | 23,245,203 | 19,531,636 | 1,690,760 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $6M | $2M | $423.5K | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-19M | $-22M | $-22M | |
| Stock Issued | $4M | $0 | · | |
| Net Stock Activity | $4M | · | · | |
| Financing Cash Flow | $24M | $28M | $4M | |
| Taxes Paid | $800 | $800 | $0 |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -190.3% | -443.2% | · | |
| ROE | -843.5% | -998.9% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 2.4 | 1.0 | · | |
| Quick Ratio | 2.3 | 1.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $0.34 | $0.01 | · | |
| Cash Flow / Share | $-0.91 | $-2.61 | · | |
| Cash / Share | $0.57 | $0.44 | · | |
| EPS (TTM) | $-1.06 | $-3.26 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-22M | $-27M | · | |
| Market Cap | $142M | $155M | · | |
| P/E | -5.8 | -2.4 | · | |
| P/B | 18.0 | 1492.3 | · | |
| P / Tangible Book | 18.0 | 1492.3 | · | |
| P / Cash Flow | -7.4 | -7.1 | · | |
| Earnings Yield | -17.3% | -40.9% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $7M | $7M | $6M | $5M | |
| SG&A Expense | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $1M | $912.8K | $969.4K | $714.2K | $807.2K | |
| Operating Expenses | $5M | $6M | $5M | $5M | $6M | $6M | $7M | $5M | $5M | $8M | $8M | $6M | $6M | |
| Operating Income | $-5M | $-6M | $-5M | $-5M | $-6M | $-6M | $-7M | $-5M | $-5M | $-8M | $-8M | $-6M | $-6M | |
| Interest Income | $45.0K | $85.3K | $139.6K | $70.0K | $24.5K | $53.6K | $118.1K | $80.7K | $8.6K | $14.8K | $59.7K | $125.9K | · | |
| Other Non-op | $40.0K | $80.2K | $134.5K | $64.9K | $19.5K | $48.6K | $113.0K | $-578.1K | $-1M | $-522.8K | $3.0K | $137.7K | $60.1K | |
| Net Income | $-5M | $-6M | $-5M | $-5M | $-6M | $-6M | $-6M | $-6M | $-7M | $-8M | $-8M | $-6M | $-6M | |
| EPS (Basic) | $-0.20 | $-0.24 | $-0.19 | $-0.25 | $-0.30 | $-0.32 | $6.89 | $-0.55 | $-4.20 | $-5.40 | $-5.11 | $-4.31 | $-3.88 | |
| EPS (Diluted) | $-0.20 | $-0.24 | $-0.19 | $-0.25 | $-0.30 | $-0.32 | $6.89 | $-0.55 | $-4.20 | $-5.40 | $-5.11 | $-4.31 | $-3.88 | |
| Shares (Basic) | 23,871,850 | 23,537,134 | · | 21,394,965 | 19,646,475 | 19,497,731 | · | 10,772,640 | 1,565,777 | 1,535,167 | · | 1,472,182 | 1,422,164 | |
| Shares (Diluted) | 23,871,850 | 23,537,134 | · | 21,394,965 | 19,646,475 | 19,497,731 | · | 10,772,640 | 1,565,777 | 1,535,167 | · | 1,472,182 | 1,422,164 | |
| EBITDA | $-5M | $-6M | · | $-5M | $-6M | $-6M | · | $-5M | $-5M | · | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $8M | $13M | $17M | $6M | $4M | · | $14M | $351.7K | · | · | · | · | |
| Prepaid Expense | $322.1K | $385.4K | $484.0K | $519.2K | $195.9K | $359.2K | $566.3K | $739.3K | $198.0K | · | $36.9K | · | · | |
| Current Assets | $5M | $9M | $14M | $17M | $7M | $4M | $9M | $14M | $549.7K | · | $3M | · | · | |
| Other Non-current Assets | $451.4K | $391.8K | $392.5K | $269.9K | $280.3K | $234.5K | $110.5K | · | · | · | $0 | · | · | |
| Total Assets | $5M | $9M | $14M | $18M | $7M | $4M | $9M | $14M | $2M | · | $3M | · | · | |
| Accounts Payable | $1M | $1M | $2M | $1M | $3M | $3M | $2M | $2M | $6M | · | $3M | · | · | |
| Current Liabilities | $4M | $5M | $6M | $6M | $9M | $9M | $9M | $8M | $20M | · | $7M | · | · | |
| Total Liabilities | $4M | $5M | $6M | $7M | $10M | $10M | $9M | $9M | $22M | · | $8M | · | · | |
| Common Stock | $24 | $24 | $23 | $23 | $20 | $20 | $20 | $20 | $2 | · | $2 | · | · | |
| Paid-in Capital | $166M | $164M | $163M | $161M | $142M | $134M | $132M | $131M | $6M | · | $5M | · | · | |
| Retained Earnings | $-165M | $-160M | $-155M | $-150M | $-145M | $-139M | $-132M | $-126M | $-120M | · | $-105M | · | · | |
| Stockholders' Equity | $989.2K | $4M | $8M | $11M | $-3M | $-5M | $104.2K | $5M | $-114M | · | $-100M | · | · | |
| Liabilities + Equity | $5M | $9M | $14M | $18M | $7M | $4M | $9M | $14M | $2M | · | $3M | · | · | |
| Shares Outstanding | 24,013,577 | 23,711,677 | 23,245,203 | 23,243,328 | 20,470,504 | 19,531,636 | 19,531,636 | 19,531,636 | 1,690,760 | · | 1,690,760 | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $566.0K | $90.0K | $148.2K | $122.0K | $155.2K | · | |
| Operating Cash Flow | $-4M | $-5M | $-4M | $-7M | $-4M | $-5M | $-5M | $-9M | $-3M | $-5M | $-6M | $-6M | · | |
| Stock Issued | $731.6K | $519.6K | $0 | $2M | $2M | $0 | $0 | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $519.6K | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $697.0K | $-8.1K | $-29.3K | $17M | $7M | $-133.5K | $-109.4K | $22M | $957.0K | $4M | $0 | $0 | · | |
| Taxes Paid | $0 | $800 | $0 | $0 | $0 | $800 | $0 | $800 | $0 | $0 | $0 | $0 | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -80.0% | -84.0% | · | -33.8% | -136.8% | -281.8% | · | -83.7% | -759.4% | · | · | · | · | |
| ROE | 584.7% | 863.3% | · | -66.4% | 10.2% | 248.3% | · | -222.8% | 11.5% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.8 | · | 2.7 | 0.7 | 0.5 | · | 1.7 | 0.0 | · | · | · | · | |
| Quick Ratio | 1.2 | 1.7 | · | 2.7 | 0.7 | 0.4 | · | 1.6 | 0.0 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.04 | $0.16 | · | $0.47 | $-0.13 | $-0.26 | · | $0.27 | $-67.58 | · | · | · | · | |
| Cash Flow / Share | · | $-0.21 | · | · | · | $-0.24 | · | · | · | · | · | · | · | |
| Cash / Share | $0.18 | $0.34 | · | $0.73 | $0.32 | $0.20 | · | $0.69 | $0.21 | · | · | · | · | |
| EPS (TTM) | $-0.88 | $-0.98 | · | $6.02 | $5.72 | $1.82 | · | $-15.26 | $-19.02 | $-18.70 | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-20M | $-22M | · | $-24M | $-25M | $-25M | · | $-28M | $-29M | $-28M | · | · | · | |
| Market Cap | $37M | $65M | · | $155M | $125M | $132M | · | $146M | · | · | · | · | · | |
| P/E | -1.7 | -2.8 | · | 1.1 | 1.1 | 3.7 | · | -0.5 | · | · | · | · | · | |
| P/B | 37.1 | 17.2 | · | 14.2 | -47.1 | -26.0 | · | 27.2 | · | · | · | · | · | |
| P / Tangible Book | 37.1 | 17.2 | · | 14.2 | · | · | · | 27.2 | · | · | · | · | · | |
| P / Cash Flow | · | -12.9 | · | · | · | -28.6 | · | · | · | · | · | · | · | |
| Earnings Yield | -57.5% | -35.8% | · | 90.0% | 93.6% | 26.9% | · | -204.8% | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net Income | $-22M | $-27M | $-25M |
| Diluted EPS | $-1.06 | $-3.26 | $-17.24 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Current Ratio | 2.4 | 1.0 | · |
| Quick Ratio | 2.3 | 1.0 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 64 filers · $23.8M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
64
Value held
$23.8M
New positions
15
Exited positions
14
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 15 (-7 vs prior Q) | 14 (+10 vs prior Q) | 18 (-2 vs prior Q) | 20 (+10 vs prior Q) | -418K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BIOS Capital Management, LP | $15,376,494 | 10,049,996 | 64.71% | Shares |
| VANGUARD GROUP INC | $3,238,159 | 529,111 | 13.63% | Shares |
| Voss Capital, LP | $2,639,250 | 1,725,000 | 11.11% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $601,952 | 393,433 | 2.53% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $195,064 | 127,493 | 0.82% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $172,207 | 112,554 | 0.72% | Shares |
| Texas Capital Bank Wealth Management Services Inc | $156,997 | 102,612 | 0.66% | Shares |
| Palogic Value Management, L.P. | $153,000 | 100,000 | 0.64% | Shares |
| MILLENNIUM MANAGEMENT LLC | $147,927 | 96,684 | 0.62% | Shares |
| BlackRock, Inc. | $137,754 | 90,035 | 0.58% | Shares |
| ABS Direct Equity Fund LLC | $111,975 | 73,186 | 0.47% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $83,380 | 54,497 | 0.35% | Shares |
| Rock Creek Group LLC | $60,072 | 39,263 | 0.25% | Shares |
| JANE STREET GROUP, LLC | $59,872 | 39,132 | 0.25% | Shares |
| HighTower Advisors, LLC | $55,785 | 36,461 | 0.23% | Shares |
| GOLDMAN SACHS GROUP INC | $54,312 | 35,498 | 0.23% | Shares |
| SFMG, LLC | $50,490 | 33,000 | 0.21% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $43,118 | 28,182 | 0.18% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $35,927 | 23,482 | 0.15% | Shares |
| STATE STREET CORP | $33,431 | 21,850 | 0.14% | Shares |
| NORTHERN TRUST CORP | $32,467 | 21,220 | 0.14% | Shares |
| Mariner, LLC | $32,257 | 21,082 | 0.14% | Shares |
| Gleason Group, Inc. | $29,113 | 19,028 | 0.12% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $28,333 | 18,518 | 0.12% | Shares |
| Qube Research & Technologies Ltd | $23,342 | 15,256 | 0.10% | Shares |
| Apollon Wealth Management, LLC | $21,440 | 14,013 | 0.09% | Shares |
| IEQ CAPITAL, LLC | $21,252 | 13,890 | 0.09% | Shares |
| ACT Advisors, LLC. | $19,702 | 12,877 | 0.08% | Shares |
| DEUTSCHE BANK AG\ | $18,720 | 12,235 | 0.08% | Shares |
| LPL Financial LLC | $18,306 | 11,965 | 0.08% | Shares |
| Sowell Financial Services LLC | $16,788 | 10,973 | 0.07% | Shares |
| Green Ridge Wealth Planning LLC | $15,300 | 10,000 | 0.06% | Shares |
| JPMORGAN CHASE & CO | $12,049 | 7,626 | 0.05% | Shares |
| Global Retirement Partners, LLC | $9,563 | 6,250 | 0.04% | Shares |
| Vanguard Global Advisers, LLC | $7,806 | 5,102 | 0.03% | Shares |
| Tower Research Capital LLC (TRC) | $5,560 | 3,634 | 0.02% | Shares |
| RHUMBLINE ADVISERS | $5,538 | 3,620 | 0.02% | Shares |
| UBS Group AG | $5,407 | 3,534 | 0.02% | Shares |
| MORGAN STANLEY | $5,340 | 3,490 | 0.02% | Shares |
| CWM, LLC | $5,116 | 1,867 | 0.02% | Shares |
| FMR LLC | $5,029 | 3,287 | 0.02% | Shares |
| PNC Financial Services Group, Inc. | $3,845 | 2,513 | 0.02% | Shares |
| WELLS FARGO & COMPANY/MN | $3,742 | 2,446 | 0.02% | Shares |
| Arax Advisory Partners | $2,004 | 1,310 | 0.01% | Shares |
| OSAIC HOLDINGS, INC. | $1,530 | 1,000 | 0.01% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $1,515 | 990 | 0.01% | Shares |
| Russell Investments Group, Ltd. | $1,030 | 673 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $1,000 | 483 | 0.00% | Shares |
| BARCLAYS PLC | $645 | 421 | 0.00% | Shares |
| CITIGROUP INC | $604 | 395 | 0.00% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| BIOS FUND I, LP, BIOS FUND I QP, LP, BIOS FUND II, LP, BIOS FUND II QP, LP, BIOS FUND II NT, LP, BIOS FUND III, LP, BIOS FUND III QP, LP, BIOS FUND III NT, LP, BP DIRECTORS, LP, BIOS ACTUATE CO-INVEST I, LP, BIOS ACTUATE CO-INVEST II, LP, BIOS ACTUATE CO-INVEST III, LP, BIOS CLINICAL OPPORTUNITY FUND, LP, BIOS 2024 CO-INVEST, LP, BIOS EQUITY PARTNERS, LP, BIOS EQUITY PARTNERS II, LP, BIOS EQUITY PARTNERS III, LP, BIOS EQUITY COF, LP, CAVU MANAGEMENT, LP, BIOS CAPITAL MANAGEMENT, LP, CAVU ADVISORS, LLC, BIOS ADVISORS GP, LLC, LESLIE W. KREIS, AARON G.L. FLETCHER ×3 filings | June 30, 2025 | 49.50% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 10 insiders · 3 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Daniel M Schmitt | President, CEO and Director | Aug. 14, 2026 M | 301,716 | 0 | 0 | $0 |
| Paul J Lytle | Chief Financial Officer | April 1, 2026 A | · | 0 | 0 | $0 |
| Mazar Andrew Paul | Chief Operating Officer | April 1, 2026 A | · | 0 | 0 | $0 |
| Dan Zabrowski | Director | May 21, 2026 A | · | 0 | 0 | $0 |
| Roger Sawhney | Director | May 21, 2026 A | · | 0 | 0 | $0 |
| Fletcher Aaron G.L. | Director | May 21, 2026 A | · | 0 | 0 | $0 |
| Jason A Keyes | Director | May 21, 2026 A | · | 0 | 0 | $0 |
| Martin H. Huber Jr. | Director | May 21, 2026 A | · | 0 | 0 | $0 |
| Amy L Ronneberg | Director | May 21, 2026 A | · | 0 | 0 | $0 |
| Todd S Thomson | Director | May 21, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
ACTU Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$12.00
+1365.2%
2 22.2%
Strong Buy
6 66.7%
Buy
1 11.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-10-03Mean target $11.68 +1326.5%
← Below all targets
Current price $0.82
Low$8.00
Mean$11.68
High$15.05
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ACTU | $142M | -5.8 | · | · | -843.5% | · |
| GRDX | $20M | -1.1 | · | -17634.4% | -68.6% | -1813.6% |
| NXTC | $50M | -0.7 | · | · | -172.9% | · |
| TCRX | · | -1.0 | 266.7% | -1256.8% | -86.6% | · |
| ATOS | $5M | -0.1 | · | · | -71.7% | · |
| ESLA | · | -4.5 | · | · | · | · |
| KPTI | $135M | -0.4 | 0.57% | -134.2% | 73.7% | · |
| JSPR | · | -0.5 | · | · | · | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026